Department of Plastic Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
Med Sci Monit. 2022 Apr 28;28:e935937. doi: 10.12659/MSM.935937.
Exosomes can be derived from mesenchymal stem cells (MSCs) and have recently been used to treat defects in the tendons. They may also have applications in treating osteoporosis. MSC-derived exosomes communicate with mesenchymal and osteogenic cells through endocrine or paracrine mechanisms and contribute factors involved in physiological and pathological orthopedic conditions associated with hypoxia and bone tumors. Also, generalized medical conditions, such as obesity, hyperglycemia, and degenerative diseases, can inhibit the osteogenic effect of MSC-derived exosomes. This review aims to present an update on the roles of MSCs and exosomes derived from MSCs in treating orthopedic diseases, such as osteoporosis, and in the repair of cartilage, tendons, and bone fractures.
外泌体可以来源于间充质干细胞(MSCs),并且最近已经被用于治疗肌腱缺陷。它们也可能在治疗骨质疏松症方面有应用。MSC 来源的外泌体通过内分泌或旁分泌机制与间充质和成骨细胞进行通讯,并有助于涉及与缺氧和骨肿瘤相关的生理和病理骨科疾病的因素。此外,一般的医疗状况,如肥胖、高血糖和退行性疾病,可以抑制 MSC 来源的外泌体的成骨作用。本综述旨在介绍 MSCs 和 MSC 来源的外泌体在治疗骨科疾病(如骨质疏松症)以及软骨、肌腱和骨折修复方面的作用的最新进展。